Volume 6, Number 4—August 2000
Evidence of Infection in Humans with Rickettsia helvetica in Eastern France
A 37-year-old man living in eastern France seroconverted to Rickettsia helvetica in August 1997, 4 weeks after the onset of an unexplained febrile illness. Results of a serosurvey of forest workers from the area where the patient lived showed a 9.2% seroprevalence against R. helvetica. This organism may pose a threat for populations exposed to Ixodes ricinus ticks.
Spotted fever group rickettsiae are gram-negative intracellular bacilli associated with arthropods and transmitted by ticks. The most common clinical features of rickettsioses in humans are fever, headache, rash, and inoculation eschar. Five well-characterized and three recently proposed rickettsioses of humans have been identified in the past 13 years. Extensively studied rickettsioses include Japanese spotted fever (caused by Rickettsia japonica), Astrakhan fever (Astrakhan fever rickettsia), Flinder's Island spotted fever (R. honei), California flea typhus (R. felis), and African tick-bite fever (R. africae). In France, R. conorii, the agent of Mediterranean spotted fever, which is transmitted through the bite of the brown dog tick (Rhipicephalus sanguineus), is the main pathogenic rickettsia and is encountered in the southern part of the country. Recently, "Rickettsia mongolotimonae," R. slovaca, and R. helvetica have also been identified as agents of human rickettsioses in Europe. Other species of unknown pathogenicity--including R. rhipicephali, R. massiliae, and Bar 29--have been isolated from ticks in Europe.
R. helvetica has been isolated from Ixodes ricinus collected in Switzerland, France, Slovenia, and Sweden. These ticks, which readily bite humans, are also the vectors in Europe of Borrelia burgdorferi and Ehrlichia phagocytophila, the agent of human granulocytic ehrlichiosis. I. ricinus is widely prevalent in parts of Europe (1), including eastern France, and frequently bites humans (Figure 1). Consequently, the potential transmission of R. helvetica by I. ricinus to humans seemed likely, but its pathogenic capacity in this regard remained uncertain until Nilsson et al. demonstrated its role in the development of perimyocarditis and sudden death in two young patients (2).
In this report, we describe a human infectious syndrome in which specific seroconversion against R. helvetica occurred. We also present the results of a serosurvey on rickettsioses conducted in Alsace (eastern France) among forest workers, which showed high prevalence of antibody reactive with this bacterium.
A 37-year-old, immunocompetent man was admitted to a hospital in Strasbourg, Alsace, on August 18, 1997, with prolonged fever, fatigue, myalgias, and headache of unknown etiology. The fever had begun on August l, 18 days after the man walked in a forest near Strasbourg, where he observed numerous ticks but not any tick bites. On physical examination, the physician observed low-grade fever (38.1°C) but no rash, lymphadenopathy or inoculation eschar.
Results of laboratory tests included an elevated C-reactive protein (48 mg/L); increased fibrinogen level (6.0 g/L); accelerated erythrocyte sedimentation rate (34 mm, first hour); leukocyte count of 6,700/mm3; platelet count of 165,000/mm3; and increased rates of alanine-aminotransferase (60 IU/L) and aspartate aminotransferase (52 IU/L). Blood cultures taken on August 18 were negative. The patient received no antibiotic treatment and recovered spontaneously within 2 weeks. Rickettsial serologic tests were performed on serum samples (taken on days 17, 27, and 86 after onset) at the Unité des Rickettsies. Antibody levels against B. burgdorferi, Francisella tularensis, E. phagocytophila, and hepatitis A, B and C viruses were measured in Strasbourg but were negative.
A convenience collection of serum samples from 379 forest workers from Alsace, all of whom were state employees, was obtained. These samples had been initially collected as part of a systematic serosurvey organized by the state department of occupational medicine to evaluate for the presence of antibodies to B. burgdorferi. This population was composed of 377 men and 2 women, 20 to 59 years of age; 360 (95.5 %) reported frequent tick bites but were clinically asymptomatic; the remaining 19 reported no tick bites. No questionnaire was administered. After informed consent from the patients, antibodies to R. helvetica, R. conorii, R. slovaca, and "R. mongolotimonae" were determined.
To determine the specificity of cross-reactions, serum samples, including those from the survey, were adsorbed with R. conorii, R. helvetica, R. slovaca or R. mongolotimonae antigens. Cross-adsorption procedures were performed (3). R. helvetica, R. conorii, R. slovaca, and "R. mongolotimonae" Western blot analyses were performed on the resultant supernatants. Purified R. helvetica, R. conorii, R. slovaca, and "R. mongolotimonae" were suspended in sterile water and adjusted to 2 mg/mL with a UV spectrophotometer. Western blotting procedures using unheated antigens were performed (4). Antibodies reacting against antigens of 20 to 50 kDa were assumed to be directed primarily against the lipopolysaccharide in R. helvetica, R. conorii, R. slovaca, and "R. mongolotimonae." Serologic specificity toward the different spotted fever group rickettsia species was determined by the relative immunoglobulin G (IgG) reactivity to species-specific antigens in the 110- to 145-kDa region. Intensity measures were compared by video image acquisition (The Imager, Appligene, Illkirch, France).
The first serum sample, taken from the patient on August 18, was negative for all tested antigens. Samples taken on August 27 and October 27 yielded IgG titers of 1:128, 1:64, 1:128 and 1:256, and IgM titers of 1:64, 1:16, 1:32 and 1:128 against R. conorii, R. slovaca, "R. mongolotimonae," and R. helvetica, respectively, but were negative for Coxiella burnetii and E. phagocytophila. Western immunoblotting of the patient's serum samples demonstrated cross-reactivity between R. helvetica, R. slovaca, "R. mongolotimonae," and R. conorii antigens, but adsorption with R. helvetica antigen eliminated all antibodies. After adsorption with R. conorii, R. slovaca, and "R. mongolotimonae" antigens, antibodies to R. helvetica were still present, but antibodies to the other three antigens were not observed, indicating that R. helvetica was the etiologic agent.
Of the 379 patients included in our serosurvey, 35 (9.2%) demonstrated anti-R. helvetica IgG titers 1:64 (16 had an IgG titer of 1:64; 13 a titer of 1:128; 5 a titer of 1:256; and one a titer of 1:512). IgM was not detected in any patient. In all positive serum samples, titers were greater against R. helvetica than against any of the other three tested antigens by two or more dilutions (Figure 2). Following adsorption with R. helvetica antigen, all antibodies were eliminated.
Epidemiologic evidence suggests that our patient was exposed to I. ricinus during his forest walk. He did not report any tick bites, but larvae or nymphs are often not detected by patients. Clinically, he presented with a prolonged low-grade fever, headache and myalgias. Unfortunately, no blood specimen was available for culture. Though neither cardiac symptoms nor a rash developed, the latter is sometimes lacking in other spotted fever group rickettsioses, such as African tick-bite fever or R. slovaca infection.
The usual method for the diagnosis of rickettsioses is serologic testing; the easiest method is microimmunofluorescence. Although serological cross-reactions are common among spotted fever group rickettsiae (6), R. helvetica is phylogenetically distant from other spotted fever group rickettsiae as well as from typhus group rickettsiae. Thus, one could expect the antibody response to this bacterium to be higher than against other spotted fever group rickettsiae. In our patient and 35 (9.2%) of 379 tested forest workers, antibody titers against R. helvetica were higher than those detected against R. conorii, R. slovaca, and "R. mongolotimonae." The specificity of the antibody response was confirmed by cross-adsorption and Western blotting. The forest workers lived in Alsace, an area where R. conorii and Rhipicephalus sp. are absent but where I. ricinus is highly prevalent, and were frequently exposed to ticks. To date, I. ricinus has only been demonstrated to harbor one rickettsial species, R. helvetica. Therefore, the observed seroprevalence was mainly or fully caused by R. helvetica. Although none of the forestry workers in our study reported any tick-bite-related disease, such results suggest that this occupational group may be exposed to the bites of I. ricinus and to R. helvetica infection. Prospective evaluation of ill patients and molecular identification of the causative agents need to be conducted.
Our data support the notions that this rickettsia, found in ticks (I. ricinus) that bite humans and are widely distributed in forest areas in Central Europe, could be frequent and that I. ricinus should be considered in the diagnosis of tick-transmitted infection in Europe.
Dr. Fournier is a physician in the French reference center for the diagnosis and study of rickettsial diseases. His research interests include the clinical and epidemiologic features of richettsioses.
- Gilot B. Bases biologiques, écologiques et cartographiques pour l'étude des maladies transmises par les tiques (Ixodidae et Argasidae) dans les alpes françaises et leur avant pays) [thesis]. Grenoble, France: Universite de Grenoble; 1985.
- Nilsson K, Lindquist O, Pahlson C. Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet. 1999;354:1169–73.
- Brouqui P, Harle JR, Delmont J, Frances C, Weiller PJ, Raoult D. African tick bite fever : an imported spotless rickettsiosis. Arch Intern Med. 1997;157:119–24.
- Teysseire N, Raoult D. Comparison of Western immunoblotting and microimmunofluoresence for diagnosis of Mediterranean spotted fever. J Clin Microbiol. 1992;30:455–60.
- Raoult D, Dasch GA. Line blot and Western blot immunoassays for diagnosis of Mediterranean spotted fever. J Clin Microbiol. 1989;27:2073–9.
- Hechemy KE, Raoult D, Fox J, Han Y, Elliott LB, Rawlings J. Cross-reaction of immune sera from patients with rickettsial diseases. J Med Microbiol. 1989;29:199–202.
Suggested citation: Fournier P-E, Grunnenberger F, Jaulhac B, Gastinger G, Raoult D. Evidence of Infection in Humans with Rickettsia helvetica in Eastern France. Emerg Infect Dis [serial on the Internet]. 2000, Aug [date cited]. Available from http://wwwnc.cdc.gov/eid/article/6/4/00-0412.htm